APA (7th ed.) Citation

X, J., Y, D., Y, C., & W, W. (2026). Raltitrexed in Hepatocellular Carcinoma: Mechanistic Rationale and Clinical Evidence from Arterial-Based Therapies. Journal of hepatocellular carcinoma, 13, 601493. https://doi.org/10.2147/JHC.S601493

Chicago Style (17th ed.) Citation

X, Jia, Ding Y, Chen Y, and Wang W. "Raltitrexed in Hepatocellular Carcinoma: Mechanistic Rationale and Clinical Evidence from Arterial-Based Therapies." Journal of Hepatocellular Carcinoma 13 (2026): 601493. https://doi.org/10.2147/JHC.S601493.

MLA (9th ed.) Citation

X, Jia, et al. "Raltitrexed in Hepatocellular Carcinoma: Mechanistic Rationale and Clinical Evidence from Arterial-Based Therapies." Journal of Hepatocellular Carcinoma, vol. 13, 2026, p. 601493, https://doi.org/10.2147/JHC.S601493.